Findings derived from model systems, including SMS fibroblast cell lines and RAI1+/− mice, have provided valuable insights into cellular and molecular alterations linked to RAI1 haploinsufficiency, offering a robust foundation for understanding its role in SMS pathogenesis and for developing therapeutic strategies. Here, RAI1 is linked to Smith-Magenis syndrome.